133 related articles for article (PubMed ID: 27836213)
1. Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction.
Zanocco KA; Wu JX; Yeh MW
Surgery; 2017 Jan; 161(1):16-24. PubMed ID: 27836213
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism.
Zanocco K; Angelos P; Sturgeon C
Surgery; 2006 Dec; 140(6):874-81; discussion 881-2. PubMed ID: 17188133
[TBL] [Abstract][Full Text] [Related]
3. How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? A cost-effectiveness analysis.
Zanocco K; Sturgeon C
Surgery; 2008 Aug; 144(2):290-8. PubMed ID: 18656638
[TBL] [Abstract][Full Text] [Related]
4. Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis.
Sejean K; Calmus S; Durand-Zaleski I; Bonnichon P; Thomopoulos P; Cormier C; Legmann P; Richard B; Bertagna XY; Vidal-Trecan GM
Eur J Endocrinol; 2005 Dec; 153(6):915-27. PubMed ID: 16322399
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of parathyroidectomy for primary hyperparathyroidism.
Zanocco K; Heller M; Sturgeon C
Endocr Pract; 2011; 17 Suppl 1():69-74. PubMed ID: 21247844
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of three strategies for the surgical treatment of symptomatic primary hyperparathyroidism.
Baliski C; Nosyk B; Melck A; Bugis S; Rosenberg F; H Anis A
Ann Surg Oncol; 2008 Oct; 15(10):2653-60. PubMed ID: 18677536
[TBL] [Abstract][Full Text] [Related]
7. Operative treatment of primary hyperparathyroidism: balancing cost-effectiveness with successful outcomes.
Elaraj D; Sturgeon C
Surg Clin North Am; 2014 Jun; 94(3):607-23. PubMed ID: 24857579
[TBL] [Abstract][Full Text] [Related]
8. Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism.
Nguyen-Lee JJ; Paciuc M; Guerra R; Esnaola N; Zanocco KA; Zheng F
Surgery; 2020 Jan; 167(1):155-159. PubMed ID: 31604587
[TBL] [Abstract][Full Text] [Related]
9. Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism.
Wang TS; Cheung K; Farrokhyar F; Roman SA; Sosa JA
Surgery; 2011 Dec; 150(6):1286-94. PubMed ID: 22136852
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer.
Venkatesh S; Pasternak JD; Beninato T; Drake FT; Kluijfhout WP; Liu C; Gosnell JE; Shen WT; Clark OH; Duh QY; Suh I
Surgery; 2017 Jan; 161(1):116-126. PubMed ID: 27839930
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of parathyroidectomy compared with active surveillance in patients with mild asymptomatic primary hyperparathyroidism: a systematic review and meta-analysis of randomized-controlled studies.
Anagnostis P; Vaitsi K; Veneti S; Potoupni V; Kenanidis E; Tsiridis E; Papavramidis TS; Goulis DG
J Endocrinol Invest; 2021 Jun; 44(6):1127-1137. PubMed ID: 33074457
[TBL] [Abstract][Full Text] [Related]
12. Minimizing cost and maximizing success in the preoperative localization strategy for primary hyperparathyroidism.
Solorzano CC; Carneiro-Pla D
Surg Clin North Am; 2014 Jun; 94(3):587-605. PubMed ID: 24857578
[TBL] [Abstract][Full Text] [Related]
13. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis.
Narayan R; Perkins RM; Berbano EP; Yuan CM; Neff RT; Sawyers ES; Yeo FE; Vidal-Trecan GM; Abbott KC
Am J Kidney Dis; 2007 Jun; 49(6):801-13. PubMed ID: 17533023
[TBL] [Abstract][Full Text] [Related]
14. Is surgery necessary for 'mild' or 'asymptomatic' hyperparathyroidism?
Niederle B; Wémeau JL
Eur J Endocrinol; 2015 Sep; 173(3):D13-20. PubMed ID: 26101370
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
Komaba H; Moriwaki K; Goto S; Yamada S; Taniguchi M; Kakuta T; Kamae I; Fukagawa M
Am J Kidney Dis; 2012 Aug; 60(2):262-71. PubMed ID: 22445709
[TBL] [Abstract][Full Text] [Related]
16. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism.
VanderWalde LH; Liu IL; O'Connell TX; Haigh PI
Arch Surg; 2006 Sep; 141(9):885-9; discussion 889-91. PubMed ID: 16983032
[TBL] [Abstract][Full Text] [Related]
17. Avoiding Radical Surgery in Elderly Patients With Rectal Cancer Is Cost-Effective.
Rao C; Sun Myint A; Athanasiou T; Faiz O; Martin AP; Collins B; Smith FM
Dis Colon Rectum; 2017 Jan; 60(1):30-42. PubMed ID: 27926555
[TBL] [Abstract][Full Text] [Related]
18. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Udelsman R; Pasieka JL; Sturgeon C; Young JE; Clark OH
J Clin Endocrinol Metab; 2009 Feb; 94(2):366-72. PubMed ID: 19193911
[TBL] [Abstract][Full Text] [Related]
19. Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis.
Prica A; Chan K; Cheung M
Cancer; 2015 Aug; 121(15):2637-45. PubMed ID: 25877511
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
